JAK2 V617F
A single letter change in the JAK2 gene that jams the growth signal for blood cells in the on position. Almost everyone with polycythaemia vera has it, as do about half of those with essential thrombocythaemia or myelofibrosis.
Overview
JAK2 V617F swaps one amino acid (valine for phenylalanine at position 617) in the Janus kinase 2 enzyme, removing its brake so that red cell, platelet and white cell precursors grow without the normal hormone signals. Found in 2005, it is present in about 95 percent of polycythaemia vera and 50 to 60 percent of essential thrombocythaemia and primary myelofibrosis. The share of blood cells carrying it (the allele burden) tracks disease bulk and falls with interferon treatment, which is why it is used as a marker of molecular response.
- Target · the protein and the cell it sits on
- Drug · antibody, small molecule, cell or radioligand
- Effect · signal, damage or kill
In plain words · The signalling enzyme that tells marrow cells to make red cells and platelets; a single mutation (V617F) leaves it switched on in most myeloproliferative neoplasms.
Showing the target this term concerns: JAK2.
Similar pages
not linked directly; found by shared links- TermAquagenic pruritus
Shares Ropeginterferon alfa-2b, Ruxolitinib, Polycythaemia vera (PV), Myeloproliferative neoplasms (PV, ET, myelofibrosis) and the tags polycythaemia-vera, mpn.
- TermPost-PV myelofibrosis (spent phase)
Shares Essential thrombocythaemia (ET), Ruxolitinib, Polycythaemia vera (PV), Myeloproliferative neoplasms (PV, ET, myelofibrosis) and the tags polycythaemia-vera, mpn.
- IdeaClearing the JAK2 clone in polycythaemia vera: interferon plus mutant-selective inhibitors as a route to treatment-free remission
Shares Ropeginterferon alfa-2b, JAK2, Ruxolitinib, Polycythaemia vera (PV) and the tags polycythaemia-vera, mpn.
- TermErythromelalgia
Shares Essential thrombocythaemia (ET), Polycythaemia vera (PV), Myeloproliferative neoplasms (PV, ET, myelofibrosis) and the tags polycythaemia-vera, mpn.
- TrialRESPONSE
Shares Ruxolitinib, Polycythaemia vera (PV), Myeloproliferative neoplasms (PV, ET, myelofibrosis) and the tags polycythaemia-vera, mpn.
- TrialRESPONSE-2
Shares Ruxolitinib, Polycythaemia vera (PV) and the tags polycythaemia-vera, mpn.
- TrialPROUD-PV and CONTINUATION-PV
Shares Ropeginterferon alfa-2b, Polycythaemia vera (PV), Myeloproliferative neoplasms (PV, ET, myelofibrosis) and the tags polycythaemia-vera, mpn.
- TrialLow-PV
Shares Ropeginterferon alfa-2b, Polycythaemia vera (PV) and the tags polycythaemia-vera, mpn.